Search | TVST | ARVO Journals

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

one year visual and anatomical outcomes of Intravitreal faricimab Injection for treatment-naïve neovascular age-related macular degeneration: A single-center retrospective study

Satoru Inoda; Hidenori Takahashi; Aya Sato; Ryota Takahashi; Yuto Hashimoto; Hana Yoshida; Hironori Takahashi; Manami Misawa; Yasuo Yanagi; Hidetoshi Kawashima

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):OD69.

ARVO Annual Meeting Abstract June 2024

New Ordinal Regression and Endurance Test for Scheie Classification in Fundus Images

Hidenori Takahashi; Takafumi Sakura; Hiroshi Miyashita; Yusuke Kondo; Satoru Inoda; Takuya Takayama; Rossen M Hazarbassanov; Siamak Yousefi; Kosuke Nagaoka; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5639.

Retina January 2024

Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab

PDF

Yuto Hashimoto; Satoru Inoda; Hidenori Takahashi; Ryota Takahashi; Hana Yoshida; Yujiro Fujino; Shinichi Sakamoto; Hidetoshi Kawashima; Yasuo Yanagi
TAGS: brolucizumab, exudative age-related macular degeneration, uveitis, aqueous humor, proteins, injections, biological markers
Invest. Ophthalmol. Vis. Sci.. 2024; 65(1):8. https://doi.org/10.1167/iovs.65.1.8

ARVO Annual Meeting Abstract June 2023

Cytokine profile characteristics of the effectiveness by combined therapy of anti-vascular endothelial growth factor and corticosteroids for chronic retinal vein occlusion

Yusuke Arai; Hidenori Takahashi; Satoru Inoda; Shinichi Sakamoto; Hidetoshi Kawashima

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1778.

ARVO Annual Meeting Abstract June 2023

Short-term outcomes of switching from intravitreal brolucizumab to faricimab for neovascular age-related macular degeneration: A single-center retrospective study

Takuya Takayama; Satoru Inoda; Hidenori Takahashi; Manami Misawa; Hironori Takahashi; Hana Yoshida; Yuto Hashimoto; Ryota Takahashi; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2251.

ARVO Annual Meeting Abstract June 2023

Internal and external validation of a deep learning model for estimating non-perfusion areas from ultra-widefield fundus images

Hidenori Takahashi; Satoru Inoda; Yoichiro Hisadome; Yusuke Kondo; Hironobu Tampo; Takuya Takayama; Kosuke Nagaoka; Shinichi Sakamoto; Yusaku Katada; Toshihide Kurihara; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):229.

Retina May 2023

Attenuation of Laser-Induced Choroidal Neovascularization by Blockade of Prostaglandin D 2 Receptor 2

PDF

Hirotsugu Soga; Tatsuya Inoue; Yoshihiro Urade; Takashi Ueta; Hidetoshi Kawashima; Toshikatsu Kaburaki; Makoto Aihara
TAGS: choroidal neovascularization, lasers, prostaglandins, attenuation, mice, macrophages, vascular endothelial growth factor a
Trans. Vis. Sci. Tech.. 2023; 12(5):5. https://doi.org/10.1167/tvst.12.5.5

ARVO Annual Meeting Abstract June 2020

Estimation of the best corrected visual acuity from optical coherence tomography images using deep learning: a validation study

Hidenori Takahashi; Tetsuya Hasegawa; Satoru Inoda; Yusuke Arai; Siamak Yousefi; Hironobu Tampo; Yoshitsugu Matsui; YOSHIAKI TANAKA; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2043.

ARVO Annual Meeting Abstract July 2019

Comparison of cytokine concentrations in vitreous fluids among uveitis diseases

Toshikatsu Kaburaki; Hisako Ono; Rie Tanaka; Tomohito Sato; Masaru Takeuchi; Hideto Tozawa; Mari Katsura; Wada Youichiro; Shintaro Shirahama; Hirotsugu Soga; Hidetoshi Kawashima; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):812.

ARVO Annual Meeting Abstract July 2019

Estimation of best corrected visual acuity from optical coherence tomography images using deep learning

Yusuke Arai; Hidenori Takahashi; Siamak Yousefi; Satoru Inoda; Hironobu Tampo; Shinichi Sakamoto; Yoshitsugu Matsui; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1494.

ARVO Annual Meeting Abstract July 2019

The frequency of adverse events in non-infectious uveitis patients treated with TNF inhibitors

Chisato Agata; Toshikatsu Kaburaki; Rie Tanaka; Keiko Komae; Hidetomo Izawa; Hisae Nakahara; Hidetoshi Kawashima; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3523.

ARVO Annual Meeting Abstract July 2019

Cystoid macular edema following staged Descemet’s Membrane Endothelial Keratoplasty in Asian Eyes

Satoru Inoda; Takahiko Hayashi; Hidenori Takahashi; Itaru Oyakawa; Hideaki Yokogawa; Akira Kobayashi; Naoko Kato; Hidetoshi Kawashima

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6288.

ARVO Annual Meeting Abstract July 2018

Relationship between pachychoroid and aqueous humor concentrations of inflammatory cytokines in age-related macular degeneration

Masatoshi Onda; Hidenori Takahashi; Yuji Inoue; Xue Tan; Yusuke Arai; Ryota Takahashi; Satoru Inoda; Shinichi Sakamoto; Ichiya Sano; Yujiro Fujino; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):350.

ARVO Annual Meeting Abstract July 2018

Aqueous humour metabolic profiles in typical age-related macular degeneration and polypoidal choroidal vasculopathy

Yasuo Yanagi; Yan Gao; Lei Zhou; Hidenori Takahashi; Yujiro Fujino; Hidetoshi Kawashima; Roger W. Beuerman; Tien Yin Wong

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):371.

ARVO Annual Meeting Abstract July 2018

Deep-learning estimation of choroidal thickness from color fundus photographs: a validation study

Hidenori Takahashi; Yusuke Arai; Takehiro Yamashita; Tetsuya Hasegawa; Tomohiro Ohgami; Shozo Sonoda; Yoshiaki Tanaka; Hironobu Tampo; Satoru Inoda; Shinichi Sakamoto; Akihiro Kakehashi; Hidetoshi Kawashima; Yasuo Yanagi

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1730.

ARVO Annual Meeting Abstract July 2018

Eyelid Tumors: A 13-year Survey from a Tertiary Hospital in Japan

Hiroto Obata; Meri Watanabe; Yusuke Arai; Hidetoshi Kawashima

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5601.

ARVO Annual Meeting Abstract June 2017

Deep-learning estimation of choroidal thickness from color fundus photographs

Hironobu Tampo; Hidenori Takahashi; Yasuo Yanagi; Shin-ichi Sakamoto; Satoru Inoda; Hidetoshi Kawashima; Yuji Inoue; Yusuke Arai; Ryota Takahashi; Megumi Soeta

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):685.

ARVO Annual Meeting Abstract September 2016

Effects of central macular thickness on visual and anatomical outcomes in age-related macular degeneration patients: comparison between ranibizumab and aflibercept.

Shinichi Sakamoto; Hidenori Takahashi; Yuji Inoue; Yasuo Yanagi; Aya Sato; Mikiko Takezawa; Tatsuro Tanabe; Yujiro Fujino; Hidetoshi Kawashima

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3688.

ARVO Annual Meeting Abstract September 2016

Serum cytokine concentrations before and after starting of infliximab therapy

Hisae Nakahara; Toshikatsu Kaburaki; Rie Tanaka; Kazuyoshi Ohtomo; Mitsuko Takamoto; Ayako Karakawa; Kimiko Okinaga; Junko Matsuda; Yujiro Fujino; Hidetoshi Kawashima; Makoto Aihara

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):501.

Biochemistry and Molecular Biology February 2016

Vascular Endothelial Growth Factor (VEGF) Concentration Is Underestimated by Enzyme-Linked Immunosorbent Assay in the Presence of Anti-VEGF Drugs

PDF

Hidenori Takahashi; Yoko Nomura; Junko Nishida; Yujiro Fujino; Yasuo Yanagi; Hidetoshi Kawashima
TAGS: enzyme-linked immunosorbent assay, mass or substance concentration per volume, vascular endothelial growth factor a, bevacizumab, ranibizumab, pegaptanib
Invest. Ophthalmol. Vis. Sci.. 2016; 57(2):462-466. https://doi.org/10.1167/iovs.15-18245

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

one year visual and anatomical outcomes of Intravitreal faricimab Injection for treatment-naïve neovascular age-related macular degeneration: A single-center retrospective study

New Ordinal Regression and Endurance Test for Scheie Classification in Fundus Images

Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab

Cytokine profile characteristics of the effectiveness by combined therapy of anti-vascular endothelial growth factor and corticosteroids for chronic retinal vein occlusion

Short-term outcomes of switching from intravitreal brolucizumab to faricimab for neovascular age-related macular degeneration: A single-center retrospective study

Internal and external validation of a deep learning model for estimating non-perfusion areas from ultra-widefield fundus images

Attenuation of Laser-Induced Choroidal Neovascularization by Blockade of Prostaglandin D 2 Receptor 2

Estimation of the best corrected visual acuity from optical coherence tomography images using deep learning: a validation study

Comparison of cytokine concentrations in vitreous fluids among uveitis diseases

Estimation of best corrected visual acuity from optical coherence tomography images using deep learning

The frequency of adverse events in non-infectious uveitis patients treated with TNF inhibitors

Cystoid macular edema following staged Descemet’s Membrane Endothelial Keratoplasty in Asian Eyes

Relationship between pachychoroid and aqueous humor concentrations of inflammatory cytokines in age-related macular degeneration

Aqueous humour metabolic profiles in typical age-related macular degeneration and polypoidal choroidal vasculopathy

Deep-learning estimation of choroidal thickness from color fundus photographs: a validation study

Eyelid Tumors: A 13-year Survey from a Tertiary Hospital in Japan

Deep-learning estimation of choroidal thickness from color fundus photographs

Effects of central macular thickness on visual and anatomical outcomes in age-related macular degeneration patients: comparison between ranibizumab and aflibercept.

Serum cytokine concentrations before and after starting of infliximab therapy

Vascular Endothelial Growth Factor (VEGF) Concentration Is Underestimated by Enzyme-Linked Immunosorbent Assay in the Presence of Anti-VEGF Drugs

To View More...

You must be signed into an individual account to use this feature.